Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Aufgaben und Organisation von Neuro-Intensivstationen Kapitel lesen Erstes Kapitel lesen

2015 | OriginalPaper | Buchkapitel

36. Metabolische Störungen

verfasst von : Andreas Straube, Prof. Dr., Matthias Klein, PD Dr., Frank Erbguth, Prof. Dr., Matthias Maschke, Prof. Dr., Christoph Klawe, Dr., Dirk Sander, Prof. Dr., Max-Josef Hilz, Prof. Dr., Tjalf Ziemssen, Prof. Dr., Jochen Klucken, PD Dr., Zacharias Kohl, Dr., Jürgen Winkler, Prof. Dr., Markus Bettendorf, Prof. Dr., PD Dr. Dimitre Staykov, Jörg Berrouschot, Prof. Dr., Arnd Dörfler, Prof. Dr.

Erschienen in: NeuroIntensiv

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Im folgenden Kapitel werden die verschiedenen metabolischen Störungen betrachtet. Zunächst wird auf die allgemeinen und spezifischen neurologischen Komplikationen bei Organtransplantation eingegangen. Dann geht es um die metabolischen Enzephalopathien: Störungen der Gehirntätigkeit bei angeborenen und erworbenen Stoffwechselerkrankungen im engeren Sinn, Elektrolytstörungen, Hypovitaminosen, zerebrale Folgen einzelner Organdysfunktionen, zerebrale Hypoxien, Endotheliopathien und Mitochondropathien. Anschließend werden das Alkoholdelir und die Wernicke-Enzephalopathie erörtert. Bei zahlreichen akuten Erkrankungen von Gehirn, Rückenmark und peripherem Nervensystem treten typische Störungen vegetativer Systeme auf, deren Erkennung und Therapie insbesondere bei Intensivpatienten eine vitale Bedeutung haben kann: die autonomen Störungen. Bei der zentralen pontinen Myelinolyse kommt es zu einer akuten, vorwiegend fokal-symmetrischen Demyelinisierung im Hirnparenchym. Auch Basalganglienerkrankungen können intensivmedizinisch relevant werden. Und schließlich wird die akute Stressreaktion betrachtet, die aufgrund der vielfältigen metabolischen und endokrinen Veränderungen bei kritischen Erkrankungen entsteht. Gerade das RCVS als neuere Krankheitsentität und wichtige Differenzialdiagnose zur Vaskulitis des ZNS verdient einen eigenen Platz, in diesem Unterkapitel werden ebenfalls verwandte Syndrome wie die hypertensive Enzephalopathie und das PRES abgehandelt.
Literatur
1.
Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A, Iori AP, Arcese W (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: A prospective study. Neurology 50:1441–1445PubMedCrossRef
2.
Barba P, Pinana J, Valcarcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J (2009) Early and Late Neurological complications after reduced-intensivity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transplant 15:1439–1446PubMedCrossRef
3.
Black K, Baden L (2007) Fungal Infections of the CNS: Treatment Strategies for the Immunocompromised Patient. CNS Drugs 21:293–318PubMedCrossRef
4.
Beresford TP (2001) Neuropsychiatric complications of liver and other solid organ transplantation. Liver Transpl 7:36–45CrossRef
5.
Blanco R, De Girolami U, Jenkins RL, Khettry U (1995) Neuropathology of liver transplantation. Clin Neuropathol 14:109–117PubMed
6.
Bleggi-Torres LF, de Medeiros BC, Werner B, Neto JZ, Loddo G, Pasquini R, de Medeiros CR (2000) Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 25:301–307PubMedCrossRef
7.
Colombari RC, de Ataíde EC, Udo EY, Falcão AL, Martins LC, Boin IF (2013) Neurological complications prevalence and long-term survival after liver transplantation. Transplant Proc 45:1126–1129PubMedCrossRef
8.
Coplin WM, Cochran MS, Levine SR, Crawford SW (2001) Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 124:1043–1051PubMedCrossRef
9.
de Brabander C, Cornelissen J, Smitt PA, Vecht CJ, van den Bent MJ (2000) Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 68:36–40PubMedPubMedCentralCrossRef
10.
Faraci M, Lanino E, Dini G, Fondelli MP, Morreale G, Dallorso S, Manzitti C, Calevo MG, Gaggero R, Castagnola E, Haupt R (2002) Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 59:1895–1904PubMedCrossRef
11.
Ferrari U, Empl M, Kim KS, Sostak P, Forderreuther S, Straube A (2005) Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms. Headache 45:211–214PubMedCrossRef
12.
Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338:1741–1751PubMedCrossRef
13.
Forgacs B, Merhav HJ, Lappin J, Mieles L (2005) Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 37:1912–1914PubMedCrossRef
14.
Furlan AJ, Sila CA, Chimowitz MI, Jones SC (1992) Neurologic complications related to cardiac surgery. Neurol Clin 10:145–166PubMed
15.
Gallardo D, Ferra C, Berlanga JJ, Banda ED, Ponce C, Salar A, Alonso E, Espannol I, Riu C, Granena A (1996) Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 18:1135–1139PubMed
16.
Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, Tolosa E, Rozman C (1996) Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 46:1004–1009PubMedCrossRef
17.
Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A, EFNS (2006) EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol 13:2–9PubMedCrossRef
18.
Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U (2013) Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 88:301–305PubMedCrossRef
19.
Hou J, Major E (2005) Management of infections by the human polyomavirus JC: past, present and future. Expert Rev Anti Infect Ther 3:629–640PubMedCrossRef
20.
Ide K, Ohdan H, Tahara H, Ishiyama K, Shishida M, Irei T, Ohira M, Tashiro H, Itamoto T, Asahara T (2007) Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients. Transpl Int 20:632–635PubMedCrossRef
21.
Khedmat H, Taheri S (2013) Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD. Saudi J Kidney Dis Transpl 24:235–242PubMedCrossRef
22.
Klein M, Pfister HW, Leib SL, Koedel U (2009) Therapy of community acquired acute bacterial meningitis: the clock is running. Expert Opin Pharmacother 10:2609–2623PubMedCrossRef
23.
Lake W, Chang JE, Kennedy T, Morgan A, Salamat S, Başkaya MK (2013) A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics. Neurosurgery 72:960–970PubMedPubMedCentralCrossRef
24.
Maggioni F, Mantovan MC, Rigotti P, Cadrobbi R, Mainardi F, Mampreso E, Ermani M, Cortelazzo S, Zanchin G (2009) Headache in kidney transplantation. J Headache Pain 10:455–460PubMedPubMedCentralCrossRef
25.
Maier T, Schwarting A, Mauer D, Ross RS, Martens A, Kliem V, Wahl J, Panning M, Baumgarte S, Müller T, Pfefferle S, Ebel H, Schmidt J, Tenner-Racz K, Racz P, Schmid M, Strüber M, Wolters B, Gotthardt D, Bitz F, Frisch L, Pfeiffer N, Fickenscher H, Sauer P, Rupprecht CE, Roggendorf M, Haverich A, Galle P, Hoyer J, Drosten C (2010) Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 50:1112–1119PubMedCrossRef
26.
Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67:1567–1601PubMedCrossRef
27.
Mateen FJ, Dierkhising RA, Rabinstein AA, van de Beek D, Wijdicks EF (2010) Neurological complications following adult lung transplantation. Am J Transplant 10:908–914PubMedCrossRef
28.
Munoz P, Valerio M, Palomo J, Fernandez Yanez J, Fernandez-Cruz A, Guinea J, Bouza E (2010) Infectious and Non-Infectious Neurologic complications in heart transplant recipients. Medicine 89:166–173PubMedCrossRef
29.
Navarro V, Varnous S, Galanaud D, Vaissier E, Granger B, Gandjbakhch I, Baulac M (2010) Incidence and risk factors for seizures after heart transplantation. J Neurol 257:563–568PubMedCrossRef
30.
Niedobitek G, Mutimer DJ, Williams A, Whitehead L, Wilson P, Rooney N, Young LS, Hubscher SG (1997) Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients. Int J Cancer 73:514–520PubMedCrossRef
31.
Nymann T, Hathaway DK, Bertorini TE, Shokouh Amiri MH, Gaber AO (1998) Studies of the impact of pancreas-kidney and kidney transplantation on peripheral nerve conduction in diabetic patients. Transplant Proc 30:323–324PubMedCrossRef
32.
Padovan CS, Yousry TA, Schleuning M, Holler E, Kolb HJ, Straube A (1998) Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 43:627–633PubMedCrossRef
33.
Parizel PM, Snoeck HW, van den Hauwe L, Boven K, Bosmans JL, Van Goethem JW, Van Marck EA, Cras P, De Schepper AM, De Broe ME (1997) Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings. Am J Neuroradiol 18:1935–1938PubMed
34.
Perez-Miralles F, Sanchez-Manso JC, Almenar-Bonet L, Sevilla-Mantecon T, Martinez-Dolz L, Vilchez-Padilla JJ (2005) Incidence of and risk factors for neurologic complications after heart transplantation. Transplant Proc 37:4067–4070PubMedCrossRef
35.
Pomeranz S, Naparstek E, Ashkenazi E, Nagler A, Lossos A, Slavin S, Or R (1994) Intracranial haematomas following bone marrow transplantation. J Neurol 241:252–256PubMedCrossRef
36.
Ponticelli C, Campise MR (2005) Neurological complications in kidney transplant recipients. J Nephrol 18:521–528PubMed
37.
38.
Pustavoitau A, Bhardwaj A, Stevens R (2011) Neurological complications of transplantation. J Intensive Care Med 26:209–222PubMedCrossRef
39.
Rodriguez TE (2014) Neurologic complications of bone marrow transplantation. Handb Clin Neurol 121:1295–1304PubMedCrossRef
40.
Saner FH, Nadalin S, Radtke A, Sotiropoulos GC, Kaiser GM, Paul A (2009) Liver transplantation and neurological side effects. Metab Brain Dis 24:183–187PubMedCrossRef
41.
Senzolo M, Ferronato C, Burra P (2009) Neurologic complications after solid organ transplantation. Transplant Int 22:269–278CrossRef
42.
Sola-Valls N, Rodríguez CNY, Arcal C, Duran C, Oppenheimer F, Ribalta T, Lopez-Guillermo A, Campistol JM, Graus F, Diekmann F (2014) Primary brain lymphomas after kidney transplantation: an under-recognized problem? J Nephrol 27:95–102PubMedCrossRef
43.
Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60:842–848PubMedCrossRef
44.
Swinnen LJ (1997) Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation. Leuk Lymphoma 28:89–101PubMedCrossRef
45.
Tunkel A, Glaser C, Bloch K, Sejvar J, Marra C, Roos K, Hartman B, Kaplan S, Scheld M, Whitley R (2008) The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Disease Society of America. CID 47:303–327CrossRef
46.
Teive HA, Funke V, Bitencourt MA, de Oliveira MM, Bonfim C, Zanis-Neto J, Medeiros CR, Zétola VF, Werneck LC, Pasquini R (2008) Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in Brazil. Arq Neuropsiquiatr 66(3B):685–690PubMedCrossRef
47.
Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, Han S, Harrison ME, Stravitz TR, Muñoz S, Brown R, Lee WM, Blei AT (2005) Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11:1581–1589PubMedCrossRef
48.
Vaglio A, Manenti L, Mancini C, Chierici E, Cobelli R, Bacci F, Palmisano A, Buzio C, Bignardi L, Maggiore U (2010) EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient. Am J Transplant 10:947–951PubMedCrossRef
49.
Walker M, Zunt J (2005) Parasitic Central Nervous System Infections in Immunocompromised Hosts. CID 40:1005–1015CrossRef
50.
Wilson JR, Conwit RA, Eidelman BH, Starzl T, Elmagd AK (1994) Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 17:528–532PubMedCrossRef
51.
Yilmaz M, Cengiz M, Sanli S, Yegin A, Mesci A, Dinckan A, Hadimioglu N, Dosemeci L, Ramazanoglu A (2011) Neurological complications after liver transplantation. J Int Med Res 39:1483–1489PubMedCrossRef
52.
Zentner J, Buchbender K, Vahlensieck M (1995) Spinal epidural lipomatosis as a complication of prolonged corticosteroid therapy. J Neurosurg Sci 39:81–85PubMed
53.
Zivkovic S, Jumaa M, Barisic N, McCurry K (2009) Neurologic Complications following lung transplantation. J Neurol Sci 280:90–93PubMedCrossRef
54.
Als-Nielsen B, Gluud LL, Gluud C (2004) Non-absorbable disaccharides fpor hepatic encephalopathy: systemic review of randomised trials. BMJ 328:1046–1050PubMedPubMedCentralCrossRef
55.
Basler T, Meier-Hellmann A, Bredle D, Reinhart K (2002) Amino acid imbalance early in septic encephalopathy. Intensive Care Med 28:293–298PubMedCrossRef
56.
Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Muray J, Hansen CA (1993) Neurologic complications of critical medical illnesses. Crit Care Med 21:98–103PubMedCrossRef
57.
Bogdanski R, Blobner M, Hanel F, Kochs E (1999) Die septische Enzephalopathie. Anaesthesiol Intensivmed Notfallmed Schmerzther 34:123–130CrossRef
58.
Bolton CF, Young GB, Zochodne DW (1993) The neurological complications of sepsis. Ann Neurol 33:94–100PubMedCrossRef
59.
Bolton CF, Young GB (1989) Neurological complications in critical ill patients. In: Aminoff MJ (Hrsg) Neurology and General Medicine. Churchill Livingstone, New York, S 713–729
60.
Boon P, de Reuck J, Achten E, de Bleecker J (1991) Pancreatic encephalopathy. A case report and review of the literature. Clin Neurol Neurosurg 93:137–141PubMedCrossRef
61.
Brouns R, De Deyn PP (2004) Neurological complications in renal failure: a review
62.
63.
Butterworth RF (2000) Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Op Neurol 13:721–727CrossRef
64.
Chan C, Fryer J, Herkes G, Prelog K, Harrington T (2003) Fatal brain stem event complicating acute pancreatitis. J Clin Neurosc 10:351–358CrossRef
65.
Chen R, Young GB (1996) Metabolic encephalopathies. Ballieres Clinical Neurology 5:577–598PubMed
66.
Eggers V, Schilling A, Kox WJ, Spies C (2003) Septische Enzephalopathie. Anaesthesist 52:294–303PubMedCrossRef
67.
Erbguth F (2013) Hypoglykämie und zentrales Nervensystem. Diabetologe 9:25–32CrossRef
68.
Ferenci P (2001) Hepatische Enzephalopathie. Dtsch Med Wochenschr 126(Suppl 1):76–80CrossRef
69.
Finsterer J (2006) Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 114:217–238PubMedCrossRef
70.
71.
72.
Hamann GF (2001) Bedeutung von Störungen des Elektrolyt- und Wasserhaushaltes in der Neurologischen Intensivmedizin. Akt Neurol 28:103–113CrossRef
73.
Hansen HC (2013) Enzephalopathien und Bewusstseinsstörungen. Springer, HeidelbergCrossRef
74.
Hansen HC (2013) Enzephalopathien nach globaler Hypoxie. In: Hansen HC (Hrsg) Enzephalopathien und Bewusstseinsstörungen. Springer, Heidelberg, S 253–263CrossRef
75.
76.
77.
78.
Kim F, Nichol G, Maynard C et al (2014) Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA 311:45–52PubMedCrossRef
79.
Kramer L, Tribl B, Gendo A, Zauner G, Schneider B, Ferenci P, Madl C (2000) Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 31:30–34PubMedCrossRef
80.
81.
Lewis M, Howdle PD (2003) The neurology of liver failure. Q J Med 96:623–633CrossRef
82.
Müllges W, Stoll G (2002) Hypoxisch-ischämische Enzephalopathie. Akt Neurol 29:431–446CrossRef
83.
Nielsen N, Wetterslev J, Cronberg T et al (2013) TTM Trial Investigators. Targeted temperature management at 33 °C versus 36 °C after cardiac arrest. N Engl J Med 369:2197–2206PubMedCrossRef
84.
Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED (2000) Pathophysiology of septic encephalopathy: a review. Crit Care Med 28:3019–3024PubMedCrossRef
85.
Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 11:136–144PubMedCrossRef
86.
87.
88.
Schellinger PD et al (2003) Neurologische Komplikationen renaler Erkrankungen. Akt Neurol 30:375–381CrossRef
89.
Schwarz S, Schwab S, Fabian CW, Schellinger P, Orberk E, Hund E (1997) Sepsis: unklare Bewußtseinstrübung als Initialsymptom. Klinik und Pathophysiologie der septischen Enzephalopathie. Nervenarzt 68:292–297PubMedCrossRef
90.
Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J (2006) Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 114:1–7PubMedCrossRef
91.
Terborg C, Müllges W (2013) Septische Enzephalopathie. In: Hansen HC (Hrsg) Enzephalopathien und Bewusstseinsstörungen. Springer, Heidelberg, S 265–270CrossRef
92.
The Hypothermia After Cardiac Arrest Study Group (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. New Engl J Med 346:549–556CrossRef
93.
Weissenborn K (2013) Hepatische Enzephalopathie. In: Hansen HC (Hrsg) Enzephalopathien und Bewusstseinsstörungen. Springer, Heidelberg, S 271–277CrossRef
94.
Wijidicks EFM (1995) Neurology of critical illness Contemporary Neurological Series, Bd. 43. Davis, Philadelphia
95.
Young GB, Bolton CF, Archibald YM, Austin W, Wells GA (1992) The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 9:145–152PubMedCrossRef
96.
Awissi DK, Lebrun G, Fagnan M, Skrobik Y (2013) Alcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med 41(9 Suppl 1):57–68CrossRef
97.
Baumgärtner GR (1988) Clonidine vs. Chlordiazepoxide in the management of acute alcohol withdrawal: A preliminary report. Southern Med J 81:56–60PubMedCrossRef
98.
Bjorkqvist SE, Isohanni M, Makela R, Malinen L (1976) Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentrre double-blind comparision with placebo. Acta Psychiatr Scand 53:333–342PubMedCrossRef
99.
Chung TI, Kim JS, Park SK, Kim BS, Ahn KJ, Yang DW (2003) Diffusion weighted MR imaging of acute Wernicke’s encephalopathy. Eur J Radiol 45:256–258PubMedCrossRef
100.
Day E, Bentham P, Callaghan R, Kuruvilla T, George S (2004) Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev CD004033
101.
Fauler J, Verner L (1993) The pharmakokinetics of clonidine in high dosage. Eur J Pharmacol 45:165–167CrossRef
102.
Galluci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R (1990) Wernicke encephalopathy: MR findings in five patients. Am J Neuroradiol 11:887–892
103.
Gerke P, Hapke U, Rumpf HJ, John U (1997) Alcohol-related diseases in general hospital patients. Alcohol Alcohol 32:179–184PubMedCrossRef
104.
Harding A, Halliday G, Caine D, Kril J (2000) Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123:141–154PubMedCrossRef
105.
Harper C, Gold J, Rodrguez N, Perdices N (1989) The prevalence of the Wernicke-Korsakoff syndrome in Sydney, Australia: a prospective necropsy study. J Neurol Neurosurg Psychiatry 52:282–285PubMedPubMedCentralCrossRef
106.
He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A (2007) Interaction of Thiamine Deficiency and Voluntary Alcohol Consumption Disrupts Rat Corpus Callosum Ultrastructure. Neuropsychopharmacology 32:2207–2216PubMedCrossRef
107.
Heinz A, Mann K (2001) Neurobiologie der Alkoholabhängigkeit. Dt Ärztebl 98:2279–2283
108.
Hinze-Selche D, Weber MM, Zimmermann U, Pollmächer T (2000) Die Thiaminbehandlung in der Neurologie und Psychiatrie. Fortschr Neurol Psychiat 68:113–120CrossRef
109.
Holbrook AM, Crowther R, Lotter A, Cheng C, King D (1999) Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 160:649–655PubMedPubMedCentral
110.
Kavuk I, Agelink MW, Gaertner T, Kastrup O, Doerfler A, Maschke M, Diener HC (2003) Wernicke‘s encephalopathy: unusual contrast enhancement revealed by magnetic resonance imaging. Eur J Med Res 8:492–494PubMed
111.
Lange-Asschenfeldt C, Müller MJ, Szegedi A, Anghelescu I, Klawe C, Wetzel H (2003) Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis. Eur Addict Res 9:1–7PubMedCrossRef
112.
Littleton J (1998) Neurochemical mechanisms underlying alcohol withdrawal. Alcohol Health Res World 22:13–24PubMed
113.
Malcolm R, Ballenger JC, Sturgis ET, Anton R (1989) Double-blind controlled trial comparing carbamazepine to oxacepam treatment of alcohol withdrawal. Am J Psychiatry 146:617–621PubMedCrossRef
114.
Mann KF (2000) Alkohol: Klinik und Behandlung (Kapitel 19). In: Helmchen H, Henn F, Lauter H, Sartorius N (Hrsg) Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid, 4. Aufl. Psychiatrie der Gegenwart, Bd. 6. Springer, Berlin Heidelberg New York Tokyo, S 511–529CrossRef
115.
Maschke M, Weber J, Bonnet U, Dimitrova A, Bohrenkamper J, Sturm S, Muller BW, Gastpar M, Diener HC, Forsting M, Timmann D (2005) Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI. J Neurol 252:704–711PubMedCrossRef
116.
Maschke M, Hansen HC, Müller T, Pfausler B, Tiecks F, Schuchardt V (2012) Alkoholdelir und Verwirrtheitszustände. In: Diener HC (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie.. Thieme, Stuttgart
117.
Maschke M, Jahn K, Thier P (2011) Alkoholfolgekrankheiten. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 5.. Aufl. Kohlhammer, Stuttgart, Berlin, Köln
118.
Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction 25. Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144–151PubMedCrossRef
119.
Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J, Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164:1405–1412PubMedCrossRef
120.
Mc Grath SD (1975) A controlled trial of clomethiazole and chlordiazepoxide in the treatment of the acute withdrawal phase of alcoholism. Conference on alcoholism. Longman, London, S 81–90
121.
Ntais C, Pakos E, Kyzas P, Ioannidis JP (2005) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 20:CD005063
122.
Palmstierna T (2001) A model for predicting alcohol withdrawal delirium. Psychiatr Serv 52:820–823PubMedCrossRef
123.
Pitkin SR, Savage LM (2001) Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent. Behav Brain Res 119:167–177PubMedCrossRef
124.
Polycarpou A, Papanikolaou P, Ioannidis JP, Contopoulos-Ioannidis DG (2005) Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 20:CD005064
125.
Ritola E, Malinen L (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 64:254–259PubMedCrossRef
126.
Rommelspacher H, Schmidt LG, Helmchen H (1991) Pathobiochemistry and Pharmacotherapy of alcohol withdrawal. Nervenarzt 62:649–657PubMed
127.
Sechi G, Serra A (2007) Wernicke‘s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6:442–455PubMedCrossRef
128.
Seifert J, Peters E, Jahn K, Metzner C, Ohlmeier M, te Wildt B, Emrich HM, Schneider U (2004) Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance -- a pilot study. Addict Biol 9:43–51PubMedCrossRef
129.
Spies CD, Dubisz N, Neumann T, Blum S, Muller C, Rommelspacher H, Brummer G, Specht M, Sanft C, Hannemann L, Striebel HW, Schaffartzik W (1996) Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med 24:414–422PubMedCrossRef
130.
Spies CD, Otter HE, Huske B, Sinha P, Neumann T, Rettig J, Lenzenhuber E, Kox WJ, Sellers EM (2003) Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med 29:2230–2238PubMedCrossRef
131.
Sullivan EV, Pfefferbaum A (2001) Magnetic resonance relaxometry reveals central pontine abnormalities in clinically asymptomatic alcoholic men. Alcohol Clin Exp Res 25:1206–1212PubMedCrossRef
132.
Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWAAr). Br J Addict 84:1353–1357PubMedCrossRef
133.
Surges R, Beck S, Niesen WD, Weiller C, Rijntjes M (2007) Sudden bilateral blindness in Wernicke‘s encephalopathy: Case report and review of the literature. J Neurol Sci 260:261–264PubMedCrossRef
134.
Thomson AD, Marshall EJ (2006) The treatment of patients at risk of developing Wernicke‘s encephalopathy in the community. Alcohol Alcohol 41:159–167PubMedCrossRef
135.
Tong GM, Rude RK (2005) Magnesium deficiency in critical illness. J Intensive Care Med 20:3–17PubMedCrossRef
136.
Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT (1998) Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry 155:726–732PubMedCrossRef
137.
Wetterling T, Kanitz R-D, Besters B, Fischer D, Zerfass B, John U, Spranger H, Driessen M (1997) A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale). Alcohol Alcohol 32:753–760PubMedCrossRef
138.
Aggarwal A, Esler MD, Lambert GW, Hastings J, Johnston L, Kaye DM (2002) Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation 105:1031–1033PubMedCrossRef
139.
Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 213:220–222PubMedCrossRef
140.
141.
Benarroch EE (1996) Central nervous system disorders. In: Robertson D, Low PA, Polinsky RJ (Hrsg) Primer on the autonomic nervous system. Academic Press, San Diego New York Boston London Sydney Tokyo Toronto, S 226–229
142.
Biswas AK, Scott WA, Sommerauer JF et al (2000) Heart rate variability after acute traumatic brain injury in children. Crit Care Med 28:3907–12PubMedCrossRef
143.
Brignole M, Menozzi C (1997) Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope. Pace 20:795–800PubMedCrossRef
144.
Buchanan N, Cane RD, Wolfson G, DeAndrade M (1979) Autonomic dysfunction in tetanus: the effects of a variety of therapeutic agents, with special reference to morphine. Intens Care Med 5:65–68CrossRef
145.
Byer EB, Ashman R, Toth LA (1947) Electrocardiograms with large upright T-waves and long QT-intervals. Am Heart J 33:796–806PubMedCrossRef
146.
Cechtto DF, Chen SJ (1992) Hypothalamic and cortical sympathetic responses relay in the medulla of the rat. Am J Physiol 263:R544–552
147.
Cheung RT, Hachinski V (2000) The insula and cerebogenic sudden death. Arch Neurol 57:1685–1688PubMedCrossRef
148.
Dechan SC, Grant IS (1996) Haemodynamic changes in neurogenic pulmonary edema. Effect of dobutamine. Intensive Care Med 22:672–678CrossRef
149.
Di Pasquale G, Pinelli G, Andreoli A, Manini G, Grazi P, Tognetti F (1987) Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 59:596–600PubMedCrossRef
150.
Dimant J, Grob D (1977) Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 8:448–455PubMedCrossRef
151.
Englert D, von Baumgarten FJ, Gunreben G, Reifschneider G, Hassel W, Przuntek H (1985) Zur Herzschrittmacherindikation bei Polyradikulitis: Ein standardisiertes Verfahren für den Bulbusdruckversuch. In: Gänshirt H, Berlit P, Haack G (Hrsg) Verhandlungen der deutschen Gesellschaft für Neurologie. Springer, Berlin Heidelberg New York Tokyo, S 280–282
152.
Ernst ME, Klepsen ME, Fouts M, Marangus MN (1997) Tetanus: pathophysiology and management. Ann Pharmacother 31:1507–1513PubMed
153.
Flachenecker P, Hartung HP, Reiners K (1997) Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study. Brain 120:1885–1894PubMedCrossRef
154.
Flachenecker P, Reiners K (1999) Twenty-four hour heart rate power spectrum for evaluation of autonomic dysfunction in GBS. J Neurol Sci 165:144–153PubMedCrossRef
155.
Flachenecker P, Müllges W, Wermuth P, Hartung HP, Reiners K (1996) Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barré syndrome. Neurology 47:102–108PubMedCrossRef
156.
Flachenecker P, Toyka KV, Reimers K (2001) Herzrhythmusstörrungen beim Guillain-Barré-Syndrom: Eine Übersicht zur Diagnostik einer seltenen aber potenziell lebensbedrohlichen Komplikation. Nervenarzt 72:610–617PubMedCrossRef
157.
Goldstein DS (1979) The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 10:253–259PubMedCrossRef
158.
Guttmann L, Whitteridge D (1947) Effect of bladder distension on autonomic mechanisms after spinal cord injury. Brain 70:361–404PubMedCrossRef
159.
Hachinski VC (1993) The clinical problem of brain and heart. Stroke 24:1–2CrossRef
160.
Haji-Michael PG, Vincent JL, Degaute JP et al (2000) Power spectral analysis of cardiovascular variability in critically ill neurosurgical patients. 28:2578–2583
161.
Hamann G, Haass A, Schimirgk K (1993) Betablockade in acute aneurysmal subarachnoid haemorrhage. Acta Neurochir 121:119–122PubMedCrossRef
162.
Hendén PL, Söndergaard S, Rydenhag B, Reinsfelt B, Ricksten S-E, Aneman A (2014) Can baroreflex sensitivity and heart rate variability predict late neurological outcome in patients with traumatic brain injury? J Neurosurg Anesthesiol 26:50–59PubMedCrossRef
163.
Hennersdorf MG, Perings C, Niebich V et al (2000) Chemoreflex sensitivity in patients with survived sudden cardiac arrest and prior myocardial infarction. Pacing Clin Electrophys 23:457–462CrossRef
164.
Hilz MJ (2002) Quantitative autonomic functional testing in clinical trials. In: Brown WF, Bolton CF, Aminoff MJ (Hrsg) Neuromuscular Function and Disease. Basic, clinical and electrodiagnostic aspects, Bd. 2. Saunders, Philadelphia, S 1899–1929
165.
Hilz MJ, Stemper B, Neundorfer B (2000) Physiology and methods for studying the baroreceptor reflex. Fortschr Neurol Psychiatr 68:37–47PubMedCrossRef
166.
Hilz MJ, Devinsky O, Doyle W, Mauerer A, Dutsch M (2002) Decrease of cardiovascular modulation after temporal lobe epilepsy surgery. Brain 125:985–995PubMedCrossRef
167.
Jahn K, Dichgans M (2010) Herz-Hirn-Interaktion in der Intensivmedizin. Dtsch med Wochenschr 135:2347–2352PubMedCrossRef
168.
James P, Ellis CJ, Whitlock RM, McNeil AR, Henley J, Anderson NE (2000) Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. Br Med J 320:1502–1504CrossRef
169.
Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllylä VV (1996) Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemisphereic brain infarction. Stroke 27:2059–2063PubMedCrossRef
170.
Lhatoo SD, Faulkner HJ, Dembny K, Trippick K, Johnson C, Bird JM (2010) An electroclinical case-control study of sudden unexpected death in epilepsy. Ann Neurol 68:787–796PubMedCrossRef
171.
Lichtenfeld P (1970) Autonomic dysfunction in the Guillain-Barre syndrome. Am J Med 50:772–780CrossRef
172.
Lown B, Levine SA (1961) The carotid sinus. Clinical value of its stimulation. Circulation 23:766–789PubMedCrossRef
173.
Masuda T, Sato K, Yamamoto S, Matsuyama N, Shimohama T, Matsunaga A, Obuchi S, Shiba Y, Shimizu S, Izumi T (2002) Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 33:1671–1676PubMedCrossRef
174.
McDaneld LM, Fields JD, Bourdette DN, Bhardwaj A (2010) Immunomodulatory Therapies in Neurological Critical Care. Neurocrit Care 12:132–143PubMedCrossRef
175.
Mukerji S, Aloka F, Farooq MU, Kassab MY, Abela GS (2009) Cardiovascular complications oft he Guillain-Barre syndrome. Am J Cardiol 15:1452–1455CrossRef
176.
Ohtsuka T, Hamada M, Kodama K, Sasaki O, Suziki M, Hara Y, Shigematsu Y, Hiwada K (2000) Neurogenic stunned myocardium. Circulation 101:2122–2124PubMedCrossRef
177.
Oppenheimer SM, Cechetto DF, Hachinski VC (1990) Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death. Arch Neurol 47:513–519PubMedCrossRef
178.
Papaioannou V, Giannakou M, Maglaveras N, Sofianos E, Gala M (2008) Investigation of heart rate and blood pressure variability, baroreflex sensitivity, and approximate entropy in acute brain injury patients. J Crit Care 23:380–386PubMedCrossRef
179.
Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W, Winning A, Clague A, Rickard C (2000) Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 36:1328–1335PubMedCrossRef
180.
181.
Robertson D, Low PA, Polinsky RJ (1996) Primer on the autonomic nervous system. Academic press, San Diego New York Boston London Sydney Tokyo Toronto
182.
183.
Robinson TG, James M, Youde J, Panerai R, Potter J (1997) Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke 28:1671–1676PubMedCrossRef
184.
Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B (2001) Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 57:833–838PubMedCrossRef
185.
Schmidt HB, Werdan K, Müller-Werdan U (2001) Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 7:314–322PubMedCrossRef
186.
Schuchert A, Behrens G, Meinertz T (1999) Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol 22:1082–1084PubMedCrossRef
187.
Schuri U, von Cramon D (1982) Electrodermal response patterns in neurological patients with disturbed vigilance. Behav Brain Res 4:95–102PubMedCrossRef
188.
Sedy J, Zicha J, Kunes J, Jendelova P, Sykova E (2008) Mechanisms of neurogenic pulmonary edema development. Phisol Res 57:499–506
189.
Singh NK, Ljaiswal AK, Misra S, Srivastava PK (1987) Assessment of autonomic dysfunction in Guillain-Barré syndrome and its prognostic implications. Acta Neurol Scand 75:101–105PubMedCrossRef
190.
Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T (2008) Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med 36:3074–3079PubMedCrossRef
191.
Sykora M, Diedler J, Rupp A, Turcani P, Steiner T (2009) Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke 40:737–742PubMedCrossRef
192.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef
193.
Tokgozoglu SL, Batur MK, Topuoglu MA, Saribas O, Kes S, Oto A (1999) Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 30:1307–1311PubMedCrossRef
194.
Tomson T, Nashef L, Ryvlin P (2008) Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 7:1021–1031PubMedCrossRef
195.
Truijllo MH, Castillo A, Espaa J, Manzo A, Zerpa R (1987) Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 92:63–65CrossRef
196.
Vucic S, Kiernan MC, Cornblath DR (2009) Guillain-Barre syndrome: an update. J Clin Neurosci 16:309–323
197.
Walczak TS, Leppik LE, D’Amelio M, Ravick J, So E, Ahman P, Ruggles K, Cascino GD, Annegers JF, Hauser WA (2001) Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56:519–525PubMedCrossRef
198.
Winer JB, Hughes RAC (1988) Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med 257:735–739
199.
200.
Zochodone DW (1994) Autonomic involvement in Guillain-Barré syndrome: a review. Muscle &amp Nerve 17:1145–1155CrossRef
201.
Adams RD, Victor M, Mancall EL (1959) Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol Psychiatry 81:154–172CrossRef
202.
Ayus JC, Krothapalli RK, Arieff AI (1987) Treatment of symptomatic hyponatremia and its relation to brain damage: a prospective study. N Engl J Med 317:1190–1195PubMedCrossRef
203.
Bibl D, Lampl C, Gabriel C, Jüngling G, Brock H, Köstler G (1999) Treatment of central pontine myelinolysis with therapeutic plasmapheresis. Lancet 353:1155PubMedCrossRef
204.
Brown WD (2000) Osmotic demyelinisation disorders: Central pontine and extrapontine myelinolysis. Curr Opin Neurol 13:691–697PubMedCrossRef
205.
Brunner JE, Redmond JM, Haggar AM (1990) Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 27:61–66PubMedCrossRef
206.
Chang KY et al (2014) Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy. BMC Nephrol 15:56PubMedPubMedCentralCrossRef
207.
Chemaly R, Halaby G, Mohasseb G, Medlej R, Tamraz J, El-Koussa S (1998) Extrapontine myelinolysis: Treatment with TRH. Rev Neurol 154:163–165PubMed
208.
DeLuca GC, Nagy Z, Esiri MM, Davey P (2002) Evidence for a role for apoptosis in central pontine myelinolysis. Acra Neuropathol 103:590–598CrossRef
209.
Finsterer J, Engelmayer E, Trnka E, Stiskal M (2000) Immunoglobulins are effective in pontine myelinolysis. Clin Neuropharmacol 23:110–113PubMedCrossRef
210.
Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6:262–270PubMed
211.
212.
Kabeer MH, Filio RS, Milgrom JL, Pescovitz MD, Leapman SP, Lumeng L, Jindal RM (1995) Central pontine myelinolysis following orthotopic liver transplantation: Association with cyclosporine toxicity. Postgrad Med J 71:239–241PubMedPubMedCentralCrossRef
213.
Kallakatta RN et al (2011) Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry 82:326–331PubMedCrossRef
214.
Karp BI, Laureno R (1993) Pontine and extrapontine myelinolysis a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 72:359–373CrossRef
215.
King JD, Rosner MH (2010) Osmotic demyelination Syndrome. Am J Med 339:561–567CrossRef
216.
Kleinschmidt-De Masters BK, Anderson CA, Rubinstein D (1997) Asymptomatic pontine lesions found by magnetic resonance imaging: are they central pontine myelinolysis. J Neurol Sci 149:27–35CrossRef
217.
Kleinschmidt-DeMasters BK, Rojiani AM, Filley CM (2006) Central and extrapontine Myelinolysis: Then … and now. J Neuropathol Exp Neurol 65:1–11PubMedCrossRef
218.
Kumar SR, Mone AP, Gray LC, Troost BT (2000) Central pontine myelinolysis: Delayed changes on neuroimaging. J Neuroimag 10:169–172CrossRef
219.
220.
Laureno R, Karp BI (1997) Myelinolysis after correction of hyponatremia. Ann Intern Med 126:57–62PubMedCrossRef
221.
Louis G et al (2012) Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis. Crit Care Med 40:970–972PubMedCrossRef
222.
223.
Martin RJ (2004) Central pontine and extrapontine myelinolysis: the osmotic demyelination sysnromes. J Neurol Neurosurg Psychiatry 75(Suppl III):iii22–iii28PubMedPubMedCentral
224.
McKee AC, Winkelmann MD, Banker BQ (1988) Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality. Neurology 38:1211–1217PubMedCrossRef
225.
Menger H, Jörg J (1999) Outcome of central pontine and extrapontine myelinolysis (N=44). J Neurol 246:700–705PubMedCrossRef
226.
Menger H, Mackowski J, Jörg J, Cramer BM (1998) Pontine und extrapontine Myelinolysen. Frühdiagnostischer und prognostischer Wert von zerebralem CT und MRT. Nervenarzt 69:1083–1090PubMedCrossRef
227.
228.
Norenberg MD (1983) A hypothesis of osmotic endothelial injury: A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 40:66–69PubMedCrossRef
229.
Oya S, Tsutsumi K, Ueki K et al (2001) Reinduction of hyponatraemia to treat central pontine myelinolysis. Neurology 57:1931–1932PubMedCrossRef
230.
Rojiani AM, Pirenas JW, Cho ES (1994) Electrolyte induced demyelinisation in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol 88:287–292PubMedCrossRef
231.
Rojiani AM, Prineas JW, Cho ES (1987) Protective effect of steroids in electrolyte-induced demyelination. J Neuropathol Exp Neurol 46:495–504PubMedCrossRef
232.
Sadeh M, Goldhammer Y (1993) Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. Eur Neurol 33:48–50PubMedCrossRef
233.
Wright DG, Laureno R, Victor M (1979) Pontine and extrapontine myelinolysis. Brain 102:361–385PubMedCrossRef
234.
Arnold G, Trenkwalder C, Schwarz J et al (1994) Zotepine reversibly induces akinesia and rigidity in Parkinson’s disease patients with resting tremor or drug-induced psychosis. Mov Disord 9:238–240PubMedCrossRef
235.
Baratti M, Calzetti S (1984) Fluctuation of arterial blood pressure during end-of-dose akinesia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 47:1241–1243PubMedPubMedCentralCrossRef
236.
Brandstadter D, Oertel WH (2002) Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson’s disease. Neurology 58:160–161PubMedCrossRef
237.
238.
Cummings J, Isaacson S, Mills R et al (2014) Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 383:533–540. doi:10.1016/S0140-6736(13)62106-6.PubMedCrossRef
239.
Dafotakis M, Sparing R, Juzek A et al (2009) Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis. J Clin Neurosci 16:335–337PubMedCrossRef
240.
Deuschl G (2008) Tremor. In: Diener HC, Putzki H (Hrsg) Leitlinien der Deutschen Gesellschaft für Neurologie.. Thieme, Stuttgart
241.
Eichhorn TE, Brunt E, Oertel WH (1996) Ondansetron treatment of L-dopa-induced psychosis. Neurology 47:1608–1609PubMedCrossRef
242.
Factor SA, Molho ES, Friedman JH (2002) Risperidone and Parkinson’s disease. Mov Disord 17:221–222PubMedCrossRef
243.
Fenelon G, Alves G (2010) Epidemiology of psychosis in Parkinson’s disease. J Neurol Sci 289:12–17. doi:10.1016/j.jns.2009.08.014PubMedCrossRef
244.
Friedman JH, Lannon MC (1989) Clozapine in the treatment of psychosis in Parkinson’s disease. Neurology 39:1219–1221PubMedCrossRef
245.
Friedman JH, Feinberg SS, Feldman RG (1985) A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. JAMA 254:2792–2795PubMedCrossRef
246.
Goetz CG, Lutge W, Tanner CM (1986) Autonomic dysfunction in Parkinson’s disease. Neurology 36:73–75PubMedCrossRef
247.
Juncos JL, Roberts VJ, Evatt ML et al (2004) Quetiapine improves psychotic symptoms and cognition in Parkinson’s disease. Mov Disord 19:29–35PubMedCrossRef
248.
Kornhuber J, Weller M, Riederer P (1993) Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis. J Neural Transm Park Dis Dement Sect 6:63–72PubMedCrossRef
249.
Mancini F, Tassorelli C, Martignoni E et al (2004) Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 27:33–37PubMedCrossRef
250.
Manyam BV (1997) Uncommon forms of tremor. In: Watts RL, Koller WC (Hrsg) Movement Disorders Neurologic Principles and Practice. McGraw-Hill, S 387–403
251.
Morgante L, Epifanio A, Spina E et al (2002) Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson’s disease. Neurol Sci 23(Suppl 2):89–90CrossRef
252.
Morgante L, Epifanio A, Spina E et al (2004) Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol 27:153–156PubMedCrossRef
253.
Nath A, Hobson DE, Russell A (1993) Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 8:107–112PubMedCrossRef
254.
Nilsson D, Nyholm D, Aquilonius SM (2001) Duodenal levodopa infusion in Parkinson’s disease-long-term experience. Acta Neurol Scand 104:343–348PubMedCrossRef
255.
Obeso JA, Artieda J, Quinn N et al (1988) Piracetam in the treatment of different types of myoclonus. Clin Neuropharmacol 11:529–536PubMedCrossRef
256.
Oertel W, Fahn S (2003) Parkinsonism. In: Brandt T, Caplan LR, Dichgans J (Hrsg) Neurological disorders: course and treatment. Academic Press, San Diego, S 1021–1079CrossRef
257.
Oertel WH, Reichmann H (2008) Parkinson-Syndrome: Diagnostik und Therapie. In: Diener HC, Putzki H (Hrsg) Leitlinien der Deutschen Gesellschaft für Neurologie.. Thieme, Stuttgart
258.
Olanow CW, Kieburtz K, Odin P et al (2014) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson’s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 13:141–149. doi:10.1016/S1474-4422(13)70293-XPubMedCrossRef
259.
260.
Poewe W, Oertel W (1994) Parkinson’s disease. In: Hacke W (Hrsg) Neuro Critical Care. Springer, Berlin, S 883–887
261.
Poewe W, Kleedorfer B, Wagner M et al (1989) Side-effects of subcutaneous apomorphine in Parkinson’s disease. Lancet 1:1084–1085PubMedCrossRef
262.
Pollak P (2002) Psychic disorders. Rev Neurol (Paris) 158:125–131
263.
Sechi GP, Tanda F, Mutani R (1984) Fatal hyperpyrexia after withdrawal of levodopa. Neurology 34:249–251PubMedCrossRef
264.
Singer C, Berger JR, Bowen BC et al (1993) Akinetic-rigid syndrome in a 13-year-old girl with HIV-related progressive multifocal leukoencephalopathy. Mov Disord 8:113–116PubMedCrossRef
265.
Tinker R, Anderson MG, Anand P et al (1990) Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatraemia. J Neurol Neurosurg Psychiatry 53:87–88PubMedPubMedCentralCrossRef
266.
Wijdicks EF, Parisi JE, Sharbrough FW (1994) Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 35:239–243PubMedCrossRef
267.
Wolters EC, Jansen EN, Tuynman-Qua HG et al (1996) Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 47:1085–1087PubMedCrossRef
268.
Yamawaki Y, Ogawa N (1992) Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson’s disease. Intern Med 31:1298–1302PubMedCrossRef
269.
Zoldan J, Friedberg G, Livneh M et al (1995) Psychosis in advanced Parkinson’s disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology 45:1305–1308PubMedCrossRef
270.
271.
Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE (2000) Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356(9229):529–534PubMedCrossRef
272.
DeGroot LJ (2003) Non-thyroidal illness syndrome« is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. J Endocrinol Invest 26:1163–1170PubMedCrossRef
273.
Ellison DH, Berl T (2007) Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356:2064–2072PubMedCrossRef
274.
275.
Nemerovski C, Hutchinson DJ (2010) Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Clin Ther 32:1015–1032PubMedCrossRef
276.
Palmer BF (2003) Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 14:182–187PubMedCrossRef
277.
Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785–792PubMedCrossRef
278.
Van den Berghe G (2000) Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143:1–13PubMedCrossRef
279.
Van den Berghe G (2002) Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23:370–391PubMedCrossRef
280.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
281.
Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH, Yang DW, Son YM, Hahn ST (2004) Atypical manifestations of reversible posterior leukoencephalopathy syndrome: Findings on diffusion imaging and adc mapping. Neuroradiology 46:978–983PubMedCrossRef
282.
Arnold M, Camus-Jacqmin M, Stapf C, Ducros A, Viswanathan A, Berthet K, Bousser MG (2008) Postpartum cervicocephalic artery dissection. Stroke 39:2377–2379PubMedCrossRef
283.
Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036–1042PubMedCrossRef
284.
Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320–1327PubMedCrossRef
285.
Bartynski WS, Boardman JF (2008) Catheter angiography, mr angiography, and mr perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29:447–455PubMedCrossRef
286.
Bartynski WS, Sanghvi A (2003) Neuroimaging of delayed eclampsia. Report of 3 cases and review of the literature. J Comput Assist Tomogr 27:699–713PubMedCrossRef
287.
Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF (1997) Watershed imaging features and clinical vascular injury in cyclosporin a neurotoxicity. J Comput Assist Tomogr 21:872–880PubMedCrossRef
288.
Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 27:2179–2190PubMed
289.
Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW (2008) Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 29:924–930PubMedCrossRef
290.
Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J (2001) Etiology of cortical and white matter lesions in cyclosporin-a and fk-506 neurotoxicity. AJNR Am J Neuroradiol 22:1901–1914PubMed
291.
Bleys RL, Cowen T, Groen GJ, Hillen B, Ibrahim NB (1996) Perivascular nerves of the human basal cerebral arteries: I. Topographical distribution. J Cereb Blood Flow Metab 16:1034–1047PubMedCrossRef
292.
Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB (2007) Narrative review: Reversible cerebral vasoconstriction syndromes. Ann Int Med 146:34–44PubMedCrossRef
293.
Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM (1988) Reversible cerebral segmental vasoconstriction. Stroke 19:1159–1170PubMedCrossRef
294.
Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: Utility of fluid-attenuated inversion recovery mr imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206PubMed
295.
Casey SO, McKinney A, Teksam M, Liu H, Truwit CL (2004) Ct perfusion imaging in the management of posterior reversible encephalopathy. Neuroradiology 46:272–276PubMedCrossRef
296.
Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ (2006) Recurrent primary thunderclap headache and benign cns angiopathy: Spectra of the same disorder? Neurology 67:2164–2169PubMedCrossRef
297.
Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ (2008) Transcranial color doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 63:751–757PubMedCrossRef
298.
Chen SP, Fuh JL, Wang SJ, Chang FC, Lirng JF, Fang YC, Shia BC, Wu JC (2010) Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 67:648–656PubMed
299.
Coppage KH, Sibai BM (2005) Treatment of hypertensive complications in pregnancy. Curr Pharm Des 11:749–757PubMedCrossRef
300.
Dekker GA, Sibai BM (1998) Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 179:1359–1375PubMedCrossRef
301.
Diener HC, Weimar C (2012) Leitlinien für diagnostik und therapie in der neurologie. Thieme, StuttgartCrossRef
302.
Dodick DW, Brown RD Jr, Britton JW, Huston J 3rd (1999) Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalalgia an international journal of headache 19:118–123PubMedCrossRef
303.
Doss-Esper CE, Singhal AB, Smith MS, Henderson GV (2005) Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome. J Neuroimaging 15:188–192PubMed
304.
Ducros A (2012) Reversible cerebral vasoconstriction syndrome. The Lancet Neurology 11:906–917PubMedCrossRef
305.
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130:3091–3101PubMedCrossRef
306.
Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: Frequency, features, and risk factors. Stroke 41:2505–2511PubMedCrossRef
307.
308.
Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr., Barker PB (2002) Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 23:833–837PubMed
309.
Finsterer J, Schlager T, Kopsa W, Wild E (2003) Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (pres). Neurology 61:715–716PubMedCrossRef
310.
Ghia D, Cuganesan R, Cappelen-Smith C (2011) Delayed angiographic changes in postpartum cerebral angiopathy. J Clin Neurosci 18:435–436PubMedCrossRef
311.
Hauser RA, Lacey DM, Knight MR (1988) Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 45:1078–1083PubMedCrossRef
312.
Hefzy HM, Bartynski WS, Boardman JF, Lacomis D (2009) Hemorrhage in posterior reversible encephalopathy syndrome: Imaging and clinical features. AJNR Am J Neuroradiol 30:1371–1379PubMedCrossRef
313.
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedCrossRef
314.
Jones BV, Egelhoff JC, Patterson RJ (1997) Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 18:101–106PubMed
315.
Khodadad G (1973) Middle cerebral artery embolectomy and prolonged widespread vasospasm. Stroke 4:446–450PubMedCrossRef
316.
Lee JH, Martin NA, Alsina G, McArthur DL, Zaucha K, Hovda DA, Becker DP (1997) Hemodynamically significant cerebral vasospasm and outcome after head injury: A prospective study. J Neurosurg 87:221–233PubMedCrossRef
317.
Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65:205–210PubMed
318.
Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E (2012) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: The retrospective berlin pres study. J Neurol 259:155–164PubMedCrossRef
319.
Lopez-Valdes E, Chang HM, Pessin MS, Caplan LR (1997) Cerebral vasoconstriction after carotid surgery. Neurology 9:303–304CrossRef
320.
Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ (2004) Nimodipine for treatment of primary thunderclap headache. Neurology 62:1414–1416PubMedCrossRef
321.
McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M (2007) Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189:904–912PubMedCrossRef
322.
Noskin O, Jafarimojarrad E, Libman RB, Nelson JL (2006) Diffuse cerebral vasoconstriction (call-fleming syndrome) and stroke associated with antidepressants. Neurology 67:159–160PubMedCrossRef
323.
Nowak DA, Rodiek SO, Henneken S, Zinner J, Schreiner R, Fuchs HH, Topka H (2003) Reversible segmental cerebral vasoconstriction (call-fleming syndrome): Are calcium channel inhibitors a potential treatment option? Cephalalgia 23:218–222PubMedCrossRef
324.
Okanloma KA, Moodley J (2000) Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet 71:223–225PubMedCrossRef
325.
Pavlakis SG, Frank Y, Kalina P, Chandra M, Lu D (1997) Occipital-parietal encephalopathy: A new name for an old syndrome. Pediatr Neurol 16:145–148PubMedCrossRef
326.
Roth C, Ferbert A (2010) Posterior reversible encephalopathy syndrome – long-term follow-up. J Neurol Neurosurg Psychiatry 81:773–777PubMedCrossRef
327.
Schievink WI, Maya MM, Chow W, Louy C (2007) Reversible cerebral vasoconstriction in spontaneous intracranial hypotension. Headache 47:284–287PubMedCrossRef
328.
Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, Holman BL (1992) Hypertensive encephalopathy: Findings on ct, mr imaging, and spect imaging in 14 cases. AJR Am J Roentgenol 159:379–383PubMedCrossRef
329.
Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted mr imaging in hypertensive encephalopathy: Clues to pathogenesis. AJNR Am J Neuroradiol 19:859–862PubMed
330.
Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, Repke JT (2000) Preeclampsia-eclampsia: Clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217:371–376PubMedCrossRef
331.
Sekine T, Miura K, Takahashi K, Igarashi T (2009) Children’s toxicology from bench to bed-drug-induced renal injury (1): The toxic effects of arb/acei on fetal kidney development. J Toxicol Sci 34(Suppl 2):245–250
332.
Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–236PubMedCrossRef
333.
Sharma A, Whitesell RT, Moran KJ (2010) Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome. Neuroradiology 52:855–863PubMedCrossRef
334.
Singhal AB (2004) Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 61:411–416PubMedCrossRef
335.
Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ (2002) Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 58:130–133PubMedCrossRef
336.
Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH (2011) Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases. Arch Neurol 68:1005–1012PubMedCrossRef
337.
Slivka A, Philbrook B (1995) Clinical and angiographic features of thunderclap headache. Headache 35:1–6PubMedCrossRef
338.
Smeda JS, Payne GW (2003) Alterations in autoregulatory and myogenic function in the cerebrovasculature of dahl salt-sensitive rats. Stroke 34:1484–1490PubMedCrossRef
339.
Staykov D, Schwab S (2012) Posterior reversible encephalophathy syndrome. J Intensive Care Med 27:11–24PubMedCrossRef
340.
Striano P, Morana G, Rossi A, Domoto-Reilly K, Singhal AB (2011) Licorice-associated reversible cerebral vasoconstriction with pres. Neurology 77:87–88PubMedCrossRef
341.
Wakamoto H, Kume A, Nakano N, Nagao H (2006) Benign angiopathy of the central nervous system associated with phenytoin intoxication. Brain Development 28:336–338PubMedCrossRef
342.
Wilkins RH, Odom GL (1970) Intracranial arterial spasm associated with craniocerebral trauma. J Neurosurg 32:626–633PubMedCrossRef
343.
Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS, Sabourdy C, Boujan F, Jahn C, Beaujeux R, Marescaux C (2011) Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: A prospective study in 48 consecutive young patients. Stroke 42:1778–1780PubMedCrossRef
344.
Zuber M, Touze E, Domigo V, Trystram D, Lamy C, Mas JL (2006) Reversible cerebral angiopathy: Efficacy of nimodipine. J Neurol 253:1585–1588PubMedCrossRef
Metadaten
Titel
Metabolische Störungen
verfasst von
Andreas Straube, Prof. Dr.
Matthias Klein, PD Dr.
Frank Erbguth, Prof. Dr.
Matthias Maschke, Prof. Dr.
Christoph Klawe, Dr.
Dirk Sander, Prof. Dr.
Max-Josef Hilz, Prof. Dr.
Tjalf Ziemssen, Prof. Dr.
Jochen Klucken, PD Dr.
Zacharias Kohl, Dr.
Jürgen Winkler, Prof. Dr.
Markus Bettendorf, Prof. Dr.
PD Dr. Dimitre Staykov
Jörg Berrouschot, Prof. Dr.
Arnd Dörfler, Prof. Dr.
Copyright-Jahr
2015
Verlag
Springer Berlin Heidelberg
Buch
NeuroIntensiv

Print ISBN: 978-3-662-46499-1

Electronic ISBN: 978-3-662-46500-4

Copyright-Jahr: 2015

DOI
https://doi.org/10.1007/978-3-662-46500-4_36

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren